- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/81 - Protease inhibitors
Patent holdings for IPC class C07K 14/81
Total number of patents in this class: 1181
10-year publication summary
|
72
|
91
|
73
|
76
|
94
|
95
|
80
|
73
|
76
|
48
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1154 |
35 |
| Angiochem Inc. | 43 |
25 |
| Daiichi Sankyo Company, Limited | 1875 |
20 |
| Avacta Life Sciences Limited | 36 |
19 |
| Translate bio, Inc. | 416 |
19 |
| The Regents of the University of California | 20137 |
18 |
| Takeda Pharmaceutical Company Limited | 2706 |
16 |
| Cytonics Corporation | 24 |
15 |
| Sanofi Aatd Inc. | 17 |
15 |
| CSL Behring GmbH | 343 |
13 |
| Serpin Pharma, LLC | 21 |
12 |
| Biotissue Holdings Inc. | 82 |
12 |
| Genentech, Inc. | 4012 |
11 |
| ProThera Biologics, Inc. | 22 |
10 |
| Clara Foods Co., AKA Clara Foods | 101 |
10 |
| The Board of Trustees of the Leland Stanford Junior University | 6487 |
9 |
| Omeros Corporation | 308 |
9 |
| 3B Pharmaceuticals GmbH | 46 |
8 |
| University of Massachusetts | 2238 |
8 |
| Azitra, Inc. | 42 |
8 |
| Other owners | 889 |